Gentherm (THRM) Director Mascarenas Buys $533K of Stock
Key Points
- Paul Anthony Mascarenas, a Director at Gentherm Inc, purchased 20,000 shares at $26.63 each, totaling $532,600.
- Following this transaction, Mascarenas now holds 22,677 shares, representing a 747.1% increase in his stake.
- As of October 26, 2026, Gentherm's stock trades around $28.60, well below its 52-week high of $48.35.
Since the trade, $THRM is down 0.0% to date (from the $28.60 close on Oct 23, 2026).
Get Gentherm Inc text alerts
We text you when insiders, Congress, analysts or big funds move on $THRM.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Gentherm Inc alert may contain errors. Disclosures
On October 23, 2026, Paul Anthony Mascarenas, a Director at Gentherm Inc (THRM), bought 20,000 shares for $532,600. The purchase price was $26.63 per share. This transaction significantly boosted his total holdings to 22,677 shares, marking a 747.1% increase in his stake.
THRM
Gentherm Inc
Inside Paul Anthony Mascarenas's Trade
Mascarenas's recent buy shows a strong commitment to Gentherm, especially as the stock has been trading below its 50-day and 200-day moving averages. His stake now reflects a strategic move at a time when the stock is priced significantly lower than its recent highs.
Other Institutional Activity in Gentherm Inc
Several other funds have been active with Gentherm shares recently. Harvey Partners, LLC increased its holdings by 92,632 shares, bringing its total to 1,326,075 shares valued at about $37.9 million. Segall Bryant & Hamill, LLC also grew its position by 379,890 shares, now holding 1,303,973 shares worth approximately $37.3 million. Meanwhile, Global Alpha Capital Management Ltd. slightly reduced its stake by 4,886 shares, ending with 1,186,720 shares valued at about $33.9 million.
Gentherm Inc Stock Holds Steady
As of October 26, 2026, Gentherm shares are trading around $28.60, which is about 40.8% below its 52-week high of $48.35. The stock is also trading below its 50-day moving average of $35.64 and 200-day average of $34.13, indicating potential challenges in the near term.
Recent Earnings
Gentherm reported trailing twelve-month revenue of approximately $1.6 billion, with a net margin of 0.6%. The company is scheduled to announce its next earnings on February 18, 2027, which will provide further insights into its financial health.
Insider Buying and Selling at Gentherm Inc
In addition to Mascarenas's purchase, there were other insider transactions earlier this year. Wayne S Kauffman III, the General Counsel, sold 4,700 shares at $43.21 each on July 29, 2026, totaling about $203,087. Another insider, Breisacher Nicholas, sold 925 shares at the same price on August 17, 2026, amounting to roughly $39,969.
Analysts Set New Price Targets
On October 23, 2026, JP Morgan maintained its "Overweight" rating for Gentherm with a price target of $47.00. Stifel also maintained a "Buy" rating with a target of $46.00 on the same day. The consensus among analysts suggests a mean price target of $48.00, indicating a generally positive outlook.
About Gentherm Inc
Gentherm Inc is a company that designs and manufactures thermal management and comfort technologies, primarily for the automotive and medical sectors. With operations in multiple countries, it aims to enhance the user experience through innovative solutions.
Bottom Line
Investors should watch for Gentherm's next earnings report on February 18, 2027, which could provide more clarity on its performance. Mascarenas's significant purchase may signal confidence in the company's future, especially following recent analyst upgrades.
Related Filing Alerts
Source: Paul Anthony Mascarenas's Form 4 filing on $THRM (Oct 23, 2026). Written by software, not financial advice. How we make alerts